NovaBay Pharmaceuticals Reports First Quarter 2018 Financial Results

EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY), a biopharmaceutical company focusing on commercializing prescription Avenova® for the domestic eye care market, reports financial results for the three months ended March 31, 2018 and provides a business update. Unit volume through the retail pharmacy channel for the first quarter of 2018 increased 12% versus the prior-year period. Net sales for the first quarter of 2018 were $2.9 million, compared with $3

Full Story →